2004 September 3; 305(5689): 1466–1470 | Loren D. Walensky, Andrew L. Kung, Iris Escher, Thomas J. Malia, Scott Barbuto, Renee D. Wright, Gerhard Wagner, Gregory L. Verdine, and Stanley J. Korsmeyer
The study describes the development and characterization of a novel chemical strategy called hydrocarbon stapling, which enhances the pharmacological properties of BH3 peptides. This method involves using α,α-disubstituted non-natural amino acids to create a hydrocarbon "staple" that stabilizes the α-helical structure of the BH3 domain. The resulting peptides, called Stabilized Alpha-Helix of BCL-2 Domains (SAHBs), exhibit increased helicity, protease resistance, and cell permeability. SAHBs specifically bind to the binding pockets of multidomain BCL-2 members, enhancing their affinity and biological activity. A SAHB of the BH3 domain from the BID protein was shown to activate the apoptotic pathway in leukemia cells, leading to cytochrome c release and apoptosis. Additionally, SAHB effectively inhibited the growth of human leukemia xenografts in vivo, demonstrating its potential as a therapeutic agent. The study highlights the utility of hydrocarbon stapling in modulating protein-protein interactions and suggests its potential for therapeutic applications in cancer and other diseases.The study describes the development and characterization of a novel chemical strategy called hydrocarbon stapling, which enhances the pharmacological properties of BH3 peptides. This method involves using α,α-disubstituted non-natural amino acids to create a hydrocarbon "staple" that stabilizes the α-helical structure of the BH3 domain. The resulting peptides, called Stabilized Alpha-Helix of BCL-2 Domains (SAHBs), exhibit increased helicity, protease resistance, and cell permeability. SAHBs specifically bind to the binding pockets of multidomain BCL-2 members, enhancing their affinity and biological activity. A SAHB of the BH3 domain from the BID protein was shown to activate the apoptotic pathway in leukemia cells, leading to cytochrome c release and apoptosis. Additionally, SAHB effectively inhibited the growth of human leukemia xenografts in vivo, demonstrating its potential as a therapeutic agent. The study highlights the utility of hydrocarbon stapling in modulating protein-protein interactions and suggests its potential for therapeutic applications in cancer and other diseases.